ProShares UltraShort NASDAQ Biotechnology
14 hedge funds and large institutions have $7.39M invested in ProShares UltraShort NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
76% less capital invested
Capital invested by funds: $30.8M → $7.39M (-$23.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
14
Holding in Top 10
–
Calls
$21.9M
Puts
$7.67M
Top Buyers
| 1 | +$825K | |
| 2 | +$385K | |
| 3 | +$108K | |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$79.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$25.5K |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$1.56M | |
| 3 | -$1.43M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$929K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$780K |